X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12763) 12763
Publication (1526) 1526
Newsletter (961) 961
Newspaper Article (186) 186
Book Review (111) 111
Magazine Article (53) 53
Transcript (43) 43
Book Chapter (34) 34
Dissertation (19) 19
Conference Proceeding (18) 18
Report (6) 6
Data Set (2) 2
Paper (2) 2
Trade Publication Article (2) 2
Book / eBook (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8580) 8580
index medicus (4747) 4747
multiple sclerosis (4165) 4165
animals (3932) 3932
female (3557) 3557
interferon beta (3381) 3381
male (3067) 3067
interferon-beta - therapeutic use (3041) 3041
interferon-beta (2801) 2801
mice (2582) 2582
adult (2515) 2515
biological response modifiers (2469) 2469
immunology (2337) 2337
interferon (2249) 2249
clinical neurology (2001) 2001
multiple sclerosis - drug therapy (1878) 1878
middle aged (1856) 1856
interferon-beta - genetics (1624) 1624
interferon-beta - pharmacology (1498) 1498
interferon-beta - metabolism (1481) 1481
neurosciences (1446) 1446
interferon beta-1a (1415) 1415
cell line (1213) 1213
interferon-beta - immunology (1197) 1197
biochemistry & molecular biology (1194) 1194
research (1181) 1181
treatment outcome (1127) 1127
expression (1106) 1106
cells, cultured (1094) 1094
interferon-beta - administration & dosage (1048) 1048
interferon beta-1b (1013) 1013
multiple sclerosis, relapsing-remitting - drug therapy (1007) 1007
care and treatment (998) 998
virology (988) 988
activation (981) 981
health aspects (930) 930
cell biology (913) 913
interferon-beta - biosynthesis (913) 913
signal transduction (881) 881
glatiramer acetate (878) 878
therapy (851) 851
interferon-beta - adverse effects (823) 823
adjuvants, immunologic - therapeutic use (819) 819
viruses (805) 805
mice, inbred c57bl (775) 775
neurology (769) 769
double-blind (765) 765
nf-kappa-b (758) 758
gene expression (755) 755
magnetic resonance imaging (747) 747
multiple sclerosis - immunology (744) 744
pharmacology & pharmacy (719) 719
drug therapy (703) 703
cytokines (674) 674
analysis (672) 672
cells (664) 664
time factors (657) 657
gene-expression (652) 652
immunologic factors - therapeutic use (652) 652
innate immunity (641) 641
oncology (635) 635
multiple-sclerosis (634) 634
ifn-beta (609) 609
disease progression (605) 605
adolescent (603) 603
dendritic cells (603) 603
aged (600) 600
inflammation (600) 600
infection (594) 594
induction (572) 572
virus diseases (556) 556
proteins (555) 555
apoptosis (548) 548
mice, knockout (542) 542
research article (538) 538
double-stranded-rna (534) 534
article (530) 530
medical research (516) 516
cell line, tumor (503) 503
molecular sequence data (491) 491
multiple sclerosis - therapy (487) 487
rig-i (477) 477
disease (471) 471
medicine, research & experimental (468) 468
interferon-β (464) 464
abridged index medicus (461) 461
phosphorylation (459) 459
placebo-controlled trial (457) 457
toll-like receptors (455) 455
rna (439) 439
central-nervous-system (437) 437
dose-response relationship, drug (436) 436
young adult (434) 434
immunosuppressive agents - therapeutic use (432) 432
medicine, experimental (431) 431
t-cells (430) 430
disability (429) 429
gene expression regulation (426) 426
follow-up studies (424) 424
interferon-alpha - pharmacology (417) 417
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13048) 13048
Japanese (184) 184
German (171) 171
Spanish (141) 141
Chinese (106) 106
French (97) 97
Russian (95) 95
Italian (38) 38
Czech (32) 32
Polish (32) 32
Hungarian (22) 22
Portuguese (21) 21
Danish (12) 12
Dutch (10) 10
Swedish (10) 10
Finnish (7) 7
Korean (6) 6
Turkish (5) 5
Croatian (4) 4
Norwegian (4) 4
Persian (4) 4
Ukrainian (2) 2
Bosnian (1) 1
Hebrew (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain Research Bulletin, ISSN 0361-9230, 08/2019, Volume 150, pp. 297 - 306
Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by progressive cognitive decline. According to the critical role of... 
Inflammation | Alzheimer’s disease | Memory | Interferon beta
Journal Article
PLoS One, ISSN 1932-6203, 12/2010, Volume 5, Issue 12
Background: A poor vitamin D status has been associated with a high disease activity of multiple sclerosis (MS). Recently, we described associations between... 
ENCEPHALOMYELITIS | BIOLOGY | RECEPTOR | RISK | INTERFERON-BETA | FOXP3 | EXPRESSION
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 10/2014, Volume 5
Genome-wide association studies implicate dysregulation of immune mechanisms in the pathogenesis of multiple sclerosis (MS). Particularly, polymorphisms in... 
PHASE | CYTOKINES | THERAPY | PROTEIN | COLONY-STIMULATING FACTOR | GENETIC RISK | MULTIDISCIPLINARY SCIENCES | PHENOTYPE | INTERFERON-BETA
Journal Article
Annual Review of Medicine, ISSN 0066-4219, 2002, Volume 53, pp. 285 - 302
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 7, pp. 657 - 665
Summary Background Subcutaneous pegylated interferon (peginterferon) beta-1a is being developed for treatment of relapsing multiple sclerosis, with less... 
Neurology | Clinical trials | Multiple sclerosis | Biological response modifiers | Viral antigens | Interferon beta | Pain | Influenza | Interferon | Infections | Drug therapy | Drug dosages | Engineering Sciences
Journal Article
Journal of Microbiology and Biotechnology, ISSN 1017-7825, 2019, Volume 29, Issue 7, pp. 1137 - 1143
Hepatitis E virus (HEV) accounts for 20 million infections in humans worldwide. In most cases, the infections are self-limiting while HEV genotype 1 infection... 
interferon beta | Hepatitis E virus | methyltransferase
Journal Article
Journal of immunology (Baltimore, Md. : 1950), ISSN 0022-1767, 9/2015, Volume 195, Issue 5, pp. 2461 - 2471
Innate immune inflammatory responses are subject to complex layers of negative regulation at intestinal mucosal surfaces. While the type I interferon (IFN)... 
Salmonella | Interferon Beta | TLR4 | Macrophage
Journal Article
Journal of Isfahan Medical School, ISSN 1027-7595, 11/2018, Volume 36, Issue 495, pp. 1051 - 1056
Journal Article
Cell Journal, ISSN 2228-5806, 04/2020, Volume 22, Issue 1, pp. 92 - 95
Objective Multiple sclerosis (MS) is an inflammatory disease resulting in demyelination of the central nervous system (CNS). T helper 17 (Th17) subset protects... 
Multiple Sclerosis | Interferon-Beta | MicroRNA | Lymphocyte
Journal Article
2000, ISBN 9780864710703, 137
Book
JOURNAL OF CLINICAL INVESTIGATION, ISSN 0021-9738, 04/2012, Volume 122, Issue 4, pp. 1180 - 1188
Multiple sclerosis (MS) is a multifocal demyelinating disease with progressive neurodegeneration caused by an autoimmune response to self-antigens in a... 
CORTICAL DEMYELINATION | MEDICINE, RESEARCH & EXPERIMENTAL | MYELIN BASIC-PROTEIN | B-CELL | REGULATORY T-CELLS | CENTRAL-NERVOUS-SYSTEM | ENVIRONMENTAL RISK-FACTORS | INTERFERON-BETA | DIAGNOSTIC-CRITERIA | EPSTEIN-BARR-VIRUS | GENOME-WIDE ASSOCIATION
Journal Article
Blood, ISSN 0006-4971, 05/2019, Volume 133, Issue 19, pp. 2013 - 2026
Evolving evidence indicates that platelets and megakaryocytes (MKs) have unexpected activities in inflammation and infection; whether viral infections... 
DENGUE | RESPONSES | VIRUS | INHIBITION | EVENTS | ALPHA | INFECTION | INTERFERON-BETA | PLATELET ACTIVATION | HEMATOLOGY | PRESENT ANTIGEN
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 08/2016, Volume 82, p. 124
The purpose of this study was to evaluate the anticancer efficacy of interferon [beta] in combination with low dose of cisplatin on human cervical cancer... 
Interferon beta | Biological response modifiers | Cervical cancer
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 2/2018, Volume 24, Issue 2, pp. 233 - 235
Journal Article
NATURE REVIEWS NEUROLOGY, ISSN 1759-4758, 07/2015, Volume 11, Issue 7, pp. 371 - 371
A recent study has identified a variant of the SLC9A9 gene that is associated with the clinical response to IFN-beta treatment. IFN-beta induces SLC9A9... 
INTERFERON-BETA THERAPY | POLYMORPHISMS | MANAGEMENT | CLINICAL NEUROLOGY
Journal Article
Analytical Chemistry, ISSN 0003-2700, 01/2016, Volume 88, Issue 2, pp. 1138 - 1146
New and improved methods are required for the enhanced characterization of complex biopharmaceuticals, especially those with charge and glycan heterogeneity.... 
Electrophoresis, Capillary | Interferon-beta - chemistry | Humans | Mass Spectrometry | Biosimilar Pharmaceuticals - chemistry | Interferon-beta - analysis | Biosimilar Pharmaceuticals - analysis
Journal Article
JOURNAL OF EXPERIMENTAL MEDICINE, ISSN 0022-1007, 02/2010, Volume 207, Issue 2, pp. 327 - 337
Production of type I interferon (IFN; IFN-alpha beta) increases host susceptibility to Listeria monocytogenes, whereas type II IFN (IFN-gamma) activates... 
MYCOBACTERIUM-TUBERCULOSIS | MEDICINE, RESEARCH & EXPERIMENTAL | RESPONSES | CELLS | INNATE | MICE | INFECTION | CLASS-II TRANSACTIVATOR | INTERFERON-BETA | TNF-ALPHA | IMMUNOLOGY | EXPRESSION
Journal Article
Neurology, ISSN 0028-3878, 11/2006, Volume 67, Issue 9, pp. 1681 - 1683
We measured neutralizing antibodies (NABs) and the in vivo biologic response to interferon-beta on neopterin and beta(2)-microglobulin blood levels. All... 
MULTIPLE-SCLEROSIS | CLINICAL NEUROLOGY | INTERFERON-BETA
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.